This Center for AIDS Research (CFAR) renewal proposal represents collaboration between faculty at Tufts University and Brown University. The broad goals of this CFAR are: 1) to stimulate HIV/AIDS translational research; 2) to facilitate the development of junior HIV/AIDS investigators and to assist senior investigators who are new to HIV/AIDS research with a particular focus on minority investigators from underrepresented communities as defined by NIH; 3) to foster increased research on HIV/AIDS as it affects women; 5) to promote research which focuses on underserved populations, minorities, incarcerated persons, and persons who engage in substance abuse; 6) to enhance research in prevention science; 7) to facilitate education on HIV/AIDS; 8) to support advanced research on HIV nutritional, metabolic, and gastrointestinal disorders; 9) to provide unique laboratory services to investigators at both campuses; and 10) to enhance excellence in outcomes analysis and biostatistical science and to support investigators with statistical services. The cores established for this CFAR include Administration, Development, Immunovirology and Laboratory Services, HIV and Women, Prevention Science, Nutrition/Metabolism and GI, and Outcomes and Biostatistics. The Developmental Core will support pilot projects in promising new areas of HIV/AIDS research; studies by investigators new to the HIV/AIDS field; and will focus particularly on supporting the research of junior HIV/AIDS investigators. The CFAR will support one combined basic science core (Immunovirology and Laboratory Services), which will provide a variety of new or difficult to obtain assays and other services. This core will coordinate access to other existing service facilities at the collaborating institutions. CFAR funding of the HIV and Women Core, Prevention Science Core, Nutrition, Metabolism and GI Core, and Outcomes and Biostatistics Core will coordinate research with several clinical cohorts largely composed of women, minorities, substance abusers, and other groups that are underrepresented in clinical HIV/AIDS research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI042853-08
Application #
6929806
Study Section
Special Emphasis Panel (ZAI1-HSD-A (J1))
Program Officer
Namkung, Ann S
Project Start
1998-09-01
Project End
2007-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
8
Fiscal Year
2005
Total Cost
$1,607,756
Indirect Cost
Name
Miriam Hospital
Department
Type
DUNS #
063902704
City
Providence
State
RI
Country
United States
Zip Code
02906
Murphy, Matthew; Berns, Abby L; Bandyopadhyay, Utpala et al. (2018) Varicella in the prison setting: A report of three outbreaks in Rhode Island and a review of the literature. Vaccine 36:5651-5656
Sam, Soya S; Caliendo, Angela M; Ingersoll, Jessica et al. (2018) Evaluation of Performance Characteristics of Panther Fusion Assays for Detection of Respiratory Viruses from Nasopharyngeal and Lower Respiratory Tract Specimens. J Clin Microbiol 56:
Peloquin, Charles A; Phillips, Patrick P J; Mitnick, Carole D et al. (2018) Increased Doses Lead to Higher Drug Exposures of Levofloxacin for Treatment of Tuberculosis. Antimicrob Agents Chemother 62:
Linas, Benjamin P; Nolen, Shayla (2018) A Guide to the Economics of Hepatitis C Virus Cure in 2017. Infect Dis Clin North Am 32:447-459
Carroll, Jennifer J; Rich, Josiah D; Green, Traci C (2018) The More Things Change: Buprenorphine/naloxone Diversion Continues While Treatment Remains Inaccessible. J Addict Med 12:459-465
Coleman, Sharon M; Gnatienko, Natalia; Lloyd-Travaglini, Christine A et al. (2018) False-positive HIV diagnoses: lessons from Ugandan and Russian research cohorts. HIV Clin Trials 19:15-22
Sherman, Kenneth E; Rouster, Susan D; Kong, Ling X et al. (2018) Zika Virus Exposure in an HIV-Infected Cohort in Ghana. J Acquir Immune Defic Syndr 78:e35-e38
N'Guessan, Kombo F; Boyce, Ceejay; Kwara, Awewura et al. (2018) Human pegivirus (HPgV) infection in Ghanaians co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Virus Genes 54:361-367
Freiman, J Morgan; Jacobson, Karen R; Muyindike, Winnie R et al. (2018) Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit Analysis. J Acquir Immune Defic Syndr 77:405-412
Chan, Philip A; Crowley, Christina; Rose, Jennifer S et al. (2018) A Network Analysis of Sexually Transmitted Diseases and Online Hookup Sites Among Men Who Have Sex With Men. Sex Transm Dis 45:462-468

Showing the most recent 10 out of 806 publications